Development of a registry to evaluate immobilized lipase cartridge use in pediatric patients with short bowel syndrome/intestinal failure
Background: Over the past 4 years, outpatient use of an immobilized lipase cartridge (ILC) (RELiZORB®; Alcresta Therapeutics) in pediatric patients with intestinal failure (IF) and short bowel syndrome (SBS) has increased. Although ILC use has been associated with improved fat absorption and enteral...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-07-01
|
| Series: | Intestinal Failure |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950456225000016 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|